Two of the words in our brand name, placing responsible investment right at the heart of our investment philosophy.
Candriam is an affiliate of New York Life Group, a Fortune 100© company founded 175 years ago on three basic principles: the client’s best interests, a long-term vision, independence.
Find out more
"Today, each person appreciates the need to help sustain human development. We aim to use our investor skills to fulfil this ambition."
CEO, CANDRIAM
Chairman, New York Life Investment Management International
Close partners in Belgium for over 25 years now, Candriam and Belfius offer an unrivalled value proposition on the Belgian market. Candriam and Belfius is the pooling of two recognised top-of-the-range sources of know-how: responsible management of international scope and a unique experience of Private Banking and Wealth Management.
Within this framework, Candriam and Belfius share
common values: constant attention to risk control, a desire for permanent innovation, transparent communication and compliance with the strictest ethical standards.
Belfius and Candriam also share the same vision and ambition, both firmly believing in a sustainable investment strategy that generates profit not only for their clients but for Belgian society as a whole.
• Figures as at 31 December 2020. Source: Candriam
31/05/2021 | NEWS
Tobacco is considered as the leading risk factor of many chronic diseases. It is, for example, the cause of one-third of all cancers. Without radical treatment, the best way to reduce the highly avoidable associated mortality is to quit smoking.
Read more
21/01/2021 | NEWS
How can the environmental cost of the e-commerce boom be fairly assessed? Nowadays, as every industry and trade sector claims transparency over its environmental impact, and to be working on mitigating it, it would seem particularly timely to examine the issue from the specific viewpoint of its impact on climate change.
Read more
08/01/2021 | NEWS
Artificial intelligence (AI) is about to revolutionise the diagnosis, surveillance and treatment of several diseases. Driven by technological development and research progress, growth in the AI market will surge over the next decade. An explanation.
Read more